Author:
Baandrup Lone,Sørensen Jan,Lublin Henrik,Nordentoft Merete,Glenthoj Birte
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Economics, Econometrics and Finance (miscellaneous)
Reference35 articles.
1. Mangalore, R., Knapp, M.: Cost of schizophrenia in England. J. Ment. Health Policy Econ. 10(1), 23–41 (2007)
2. Stargardt, T., Weinbrenner, S., Busse, R., et al.: Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care. J. Ment. Health Policy Econ. 11(2), 89–97 (2008)
3. Canales, P.L., Olsen, J., Miller, A.L., et al.: Role of antipsychotic polypharmacotherapy in the treatment of schizophrenia. CNS Drugs 12(3), 179–188 (1999)
4. Botts, S., Hines, H., Littrell, R.: Antipsychotic polypharmacy in the ambulatory care setting, 1993–2000. Psychiatr. Serv. 54(8), 1086 (2003)
5. Broekema, W.J., de Groot, I.W., Van Harten, P.N.: Simultaneous prescribing of atypical antipsychotics, conventional antipsychotics and anticholinergics-a European study. Pharm. World Sci. 29(3), 126–130 (2007)
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献